Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Priya Sachdeva
UBS
Priya Sachdeva
UBS
Wall Street Analyst
★★★☆☆
#1635
on 13Foresight · ranked by our own returns
0%
Success Rate
-5.1%
Average Return
0 of 4 calls profitable · -11.8% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 0% of Priya Sachdeva's ratings turned a profit when each position was held for 1 year — averaging -5.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

5 Buy 3 Hold 0 Sell
Priya's Stock Coverage 3 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
MDT
Medtronic
 Jun 04, 2026 HOLD Buy
+23.5% avg upside
38 analysts
$85.00
7.09% Upside
 -3.2%
PEN
Penumbra
 Jan 20, 2026 HOLD Buy
+4.4% avg upside
23 analysts
$374.00
17.88% Upside
 -11.1%
NPCE
NeuroPace
 Dec 16, 2025 BUY Strong Buy
+12.2% avg upside
11 analysts
$22.00
40.75% Upside
 -4.5%
Priya Sachdeva — Frequently Asked Questions
How accurate are Priya Sachdeva's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Priya's ratings were profitable over a one-year hold, with an average return of -5.1% per rating, or -11.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Priya ranked on 13Foresight?
Priya Sachdeva is currently ranked #1635 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Priya cover?
Priya most recently has ratings on MDT, PEN, NPCE. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.